You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Details for New Drug Application (NDA): 214219

✉ Email this page to a colleague

« Back to Dashboard

NDA 214219 describes TRIAZOLAM, which is a drug marketed by Breckenridge, Hikma, Novast Labs, Pharmobedient, Watson Labs, and Zydus Pharms, and is included in six NDAs. It is available from six suppliers. Additional details are available on the TRIAZOLAM profile page.

The generic ingredient in TRIAZOLAM is triazolam. There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the triazolam profile page.

Summary for 214219

Tradename:	TRIAZOLAM
Applicant:	Novast Labs
Ingredient:	triazolam
Patents:	0

Pharmacology for NDA: 214219

Medical Subject Heading (MeSH) Categories for 214219

Adjuvants, Anesthesia
Anti-Anxiety Agents
GABA Modulators

Suppliers and Packaging for NDA: 214219

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TRIAZOLAM	triazolam	TABLET;ORAL	214219	ANDA	A-S Medication Solutions	50090-6471	50090-6471-0	30 TABLET in 1 BOTTLE (50090-6471-0)
TRIAZOLAM	triazolam	TABLET;ORAL	214219	ANDA	A-S Medication Solutions	50090-6471	50090-6471-1	100 TABLET in 1 BOTTLE (50090-6471-1)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	0.125MG
Approval Date:	Oct 20, 2020	TE:	AB	RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	0.25MG
Approval Date:	Oct 20, 2020	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.